 EditorialJournal of hematology & oncology: A journal open to allDelong Liu  Associate Professor of Medicine, New York Medical College, Munger Pavilion 250, Valhalla, NY 10595, USA  author email corresponding author email
Journal of Hematology & Oncology 2008,
1:1doi:10.1186/1756-8722-1-1 First paragraph (this article has no abstract)
Paul Ehrlich prophesied "magic bullet" in early 1900 [1], but it was not until 1975 that Kohler and Milstein developed the hybridoma technology [2]. Since then hematology and oncology have become closely intertwined and rapidly evolving fields. New findings from laboratory-based research are rapidly being turned into clinical applications. Within less than a decade, targeted therapy has become a treatment of choice for many diseases, with imatinib and rituximab representing the many recent major breakthroughs in cancer therapy [3,4]. | 
on Google Scholar
